DCF ADVISERS, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
DCF ADVISERS, LLC portfolio value:
$280,000
portfolio value
DCF ADVISERS, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -72.00% | -3.6K shares | -449K | $200.16 | 1.4K |
| Q2 2022 | share | Decrease | -73.68% | -14K shares | -2.37M | $145.85 | 5K |
| Q1 2022 | share | Increase | +5.56% | 1K shares | 51K | $163.29 | 19K |
| Q4 2021 | share | Increase | +2.86% | 500 shares | -252K | $171.03 | 18K |
| Q3 2021 | share | 0.00% | 0 shares | 337K | $188.81 | 17.5K | |
| Q2 2021 | share | Decrease | -12.50% | -2.5K shares | 143K | $169.52 | 17.5K |
| Q1 2021 | share | 0.00% | 0 shares | 225K | $141.19 | 20K | |
| Q4 2020 | share | Decrease | -27.27% | -7.5K shares | -1.40M | $129.97 | 20K |
| Q3 2020 | share | 0.00% | 0 shares | -69K | $145.6 | 27.5K | |
| Q2 2020 | share | Decrease | -5.17% | -1.5K shares | 916K | $148.11 | 27.5K |
| Q1 2020 | share | Decrease | -27.50% | -11K shares | -1.45M | $108.85 | 29K |
| Q4 2019 | share | Increase | 0.00% | 40K shares | 4.60M | $115.17 | 40K |